All News

A December 9 hearing of the U.S. Senate Special Committee on Aging had senators looking closely at several possible solutions to the recent, massive price spikes for particular generic drugs, including having FDA speed approval for competitors for products with no competition.

The Market Tightens

How was business in 2015? What do you see coming in 2016? Drug Topics' annual business outlook survey took your input and put it all together.

Drug Topics Voices

Posts, e-mails, comments, and letters from Drug Topics readers